{
  "docId": "019de073-f0bf-7547-8ad6-12100ed22e83",
  "docSlug": "a88a01f7711a3a01e2c4b1dc80e80f39",
  "documentTitle": "BenevolentAI | Investor Conference Presentation Deck | 17 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 17,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "other",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 18,
  "notes": "The chart uses a timeline-like progression (Target ID to Phase III) to visualize drug development stages.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de073-f0bf-7547-8ad6-12100ed22e83/11",
  "deckHref": "/decks/019de073-f0bf-7547-8ad6-12100ed22e83",
  "deckJsonHref": "/decks/019de073-f0bf-7547-8ad6-12100ed22e83.json",
  "deckAnchorHref": "/decks/019de073-f0bf-7547-8ad6-12100ed22e83#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.28,
        "x": 0.68,
        "y": 0.6
      },
      "kind": "callout",
      "text": "Broad disease coverage given platform. Balance of risk between “best in class” and “first in class” drug candidates",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "28d8c18b-f4ac-4c54-a14e-81b4f3f1a4d7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.28,
        "x": 0.68,
        "y": 0.2
      },
      "kind": "callout",
      "text": "BEN-2293 - Phase Ib complete, Phase IIa ongoing",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a730df0-c7a7-47e7-a744-867c0c80ca54",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.28,
        "x": 0.68,
        "y": 0.35
      },
      "kind": "callout",
      "text": "BEN-8744 - Novel target - zero prior linkage to UC. 2 years from target validation to candidate selection",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ed3f5858-e660-445c-9c41-320e560fedd0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.6,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "chart",
      "text": "Pipeline development stages chart",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d707ad59-069f-43fa-b591-4dc8e9c36a2f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Internal validation: pipeline generated from the Benevolent Platform™",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4bc6c934-93d2-47ba-9e46-baf601f065e2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 17,
      "from": 9,
      "beatId": "992080ec-aa6d-4a45-852f-5530c22dd391",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 9-17 provide relief, highlighting the validation and potential of BenevolentAI's platform, as well as its business model and future prospects.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 9,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "19fab5b9-e3e3-4fbb-b33b-153e51cd2eef",
      "evidence": "The document showcases the validation and potential of BenevolentAI's platform, highlighting its ability to deliver quick wins and support big bets in pharma R&D.",
      "position": 1,
      "objective": "What are the potential benefits of BenevolentAI's platform?",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}